Medicare AdvantagePrior AuthLow impact
Alunbrig (brigatinib) (Revised)
Humana·Oncology, Pulmonology·Medicare Advantage
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage has updated prior authorization requirements for Alunbrig (brigatinib) tablets effective January 1, 2026. The policy requires prior auth for members with advanced/metastatic non-small cell lung cancer (NSCLC) with ALK positivity, and the medication must be given as monotherapy.
Action Required
By January 1, 2026: Billing team must ensure prior authorization is obtained for all Alunbrig (brigatinib) prescriptions for Humana Medicare Advantage members. Verify patient has documented ALK-positive advanced/metastatic NSCLC and that medication will be used as monotherapy before submitting claims. Claims without prior authorization will be denied.